BeStock  
Stocks › Biotechnology › JANX

Janux Therapeutics JANX

US equityMarket cap rank #3470Biotechnology
$10.08 −$0.21 (-2.04%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $10.15 +0.69%
Open$10.11
Prev close$10.29
Day range$10.05 – $10.54
Volume1.11M
Market cap$616.73M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership103.8%+1.82 pts vs. prior quarter
Institutions holding256+0 vs. prior quarter
Insider trades (recent)38 buys / 12 sellsNet buying
Short interest8.72% of floatDays to cover 8.0 · as of 30 Oct 2026
Short-sale volume share20.3%5-day average of daily volume

Short-sale volume as % of daily volume

5%18%31%43%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$793.6K (10 inflow days, 10 outflow days).

Net flow by order size, last 20 sessions

−$2.0MSuper+$1.3MBig+$2.0MMid+$3.4MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 44.3% of shares outstanding.

Largest holders

  • RA Capital Management, L.P.18.29%
  • BlackRock10.68%
  • Prosight Management, LP6.22%
  • Klaus Dorner4.90%
  • Federated Hermes, Inc.4.24%
  • FMR4.07%
  • State Street Global Advisors3.78%
  • Vanguard Capital Management, LLC3.52%

By investor type

  • Mutual Fund46.76%
  • Hedge Fund27.16%
  • VC/PE Fund22.07%
  • Individual/Insider5.91%
  • Public Company4.75%
  • Private Company1.57%
  • Insurance Company1.16%
  • Government Pension Fund0.28%

Reported short interest has fallen from 10.84% to 8.72% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
BlackRock Mutual Fund 2026/Q3 +400,075 10.7%
Vanguard Capital Management, LLC Mutual Fund 2026/Q3 +295,787 3.5%
Federated Hermes, Inc. Mutual Fund 2026/Q3 +241,795 4.2%
Connor, Clark & Lunn Investment Management Ltd. Mutual Fund 2026/Q3 +178,181 0.5%
Morgan Stanley Public Company 2026/Q3 +124,621 1.6%
Morgan Stanley Investment Management Inc. Mutual Fund 2026/Q3 +124,621 1.6%
Creative Planning, Inc. Mutual Fund 2026/Q3 +123,970 0.3%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +573,337 0.9%
Federated Hermes, Inc. Mutual Fund 2026/Q3 +2,298,727 3.8%
Two Sigma Investments, LP Hedge Fund 2026/Q3 +1,091,151 2.0%
D. E. Shaw & Co., L.P. Hedge Fund 2026/Q3 +998,114 1.8%
Citadel Advisors LLC Hedge Fund 2026/Q3 +848,560 2.0%
Point72 Asset Management, L.P. Hedge Fund 2026/Q3 +837,697 3.3%
BlackRock Mutual Fund 2026/Q3 +701,434 10.0%
Algert Global LLC Hedge Fund 2026/Q3 +667,492 1.8%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
30 Jul 2026 David Campbell President, Co-Founder, CEO & Director Other Disposition -123,840 – 107,392
7 Jul 2026 David Campbell President, Co-Founder, CEO & Director Derivative Exercise and Retained +7,000 $4.21 231,232
10 Jun 2026 Vickie Capps Independent Director Other Acquisition +5,500 – 5,500
10 Jun 2026 Vickie Capps Independent Director Other Derivative Acquisition +15,500 $13.66 15,500
10 Jun 2026 Ronald Barrett Independent Chairperson Other Acquisition +5,500 – 5,500
10 Jun 2026 Ronald Barrett Independent Chairperson Other Derivative Acquisition +15,500 $13.66 15,500
10 Jun 2026 Eric Dobmeier Independent Director Other Acquisition +5,500 – 7,444
10 Jun 2026 Eric Dobmeier Independent Director Other Derivative Acquisition +15,500 $13.66 15,500
10 Jun 2026 Natasha Hernday Independent Director Other Acquisition +5,500 – 7,444
10 Jun 2026 Natasha Hernday Independent Director Other Derivative Acquisition +15,500 $13.66 15,500
10 Jun 2026 Winston Kung Independent Director Other Acquisition +5,500 – 5,500
10 Jun 2026 Winston Kung Independent Director Other Derivative Acquisition +15,500 $13.66 15,500
10 Jun 2026 Jake Simson Independent Director Other Acquisition +5,500 – 5,500
10 Jun 2026 Jake Simson Independent Director Other Derivative Acquisition +15,500 $13.66 15,500
1 Jun 2026 Janeen Doyle Chief Corporate & Business Development Officer Open Market Disposition -4,059 $14.03 36,000
10 May 2026 Maria Dobek Vice President of Accounting Open Market Disposition -2,038 $14.17 2,835
1 Feb 2026 William Go Former Chief Medical Officer Other Acquisition +44,000 – 44,000
1 Feb 2026 William Go Former Chief Medical Officer Other Derivative Acquisition +154,000 $13.99 154,000
1 Jan 2026 David Campbell President, Co-Founder, CEO & Director Other Acquisition +96,600 – 157,350
1 Jan 2026 David Campbell President, Co-Founder, CEO & Director Open Market Disposition -8,072 $13.73 224,232

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 5,329,932 8.7% 8.0
15 Oct 2026 5,327,163 8.7% 6.2
30 Sep 2026 5,684,346 9.3% 5.9
15 Sep 2026 5,891,965 9.6% 5.9
31 Aug 2026 6,063,535 9.9% 7.8
14 Aug 2026 6,626,696 10.8% 10.9

Discussion

No comments yet — be the first to weigh in on JANX.

Sign in to join the discussion.

Scroll to Top